Do age and comorbidity affect quality of life or PTA-induced quality-of-life improvements in patients with symptomatic PAD?

Journal of Endovascular Therapy

Volumn 12, Issue 3, 2005, Pages 387-393

  Kügler, Christian F A ^a,c   Rudofsky, Gottfried ^b  

^a Center of Vascular Medicine   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Abteilung Angiologie   (Germany)

Author keywords

Aging; Comorbidity; Percutaneous transluminal angioplasty; Peripheral arterial disease; Quality of life

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CHRONIC DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; INTERMITTENT CLAUDICATION; LEG PAIN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SELF REPORT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 20444487705     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/04-1449.1     Document Type: Article

References (32)

1. Kannel WB. The demographics of claudication and the aging of the American population. Vasc Med. 1996;1:60-64.
2. Kügler C. Peripheral arterial disease: aging and comorbidity. In: Lanzer P, Topol E, eds. Pan-Vascular Medicine-Integrated Clinical Management. Berlin: Springer Verlag; 2002:1449-1470.
3. Kügler C, Rudofsky G. The role of comorbidity burden for patients with symptomatic peripheral arterial occlusive disease. A quantitative approach. Int Angiol. 2003;22:290-301.
4. Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004;172:95-105.
5. Matsi PJ, Manninen HI, Suhonen MT. Chronic critical limb ischemia: prospective trial of angioplasty with 1-36 month of follow-up. Radiology. 1993;188:381-387.
6. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Int Angiol. 2000;19(Suppl 1):101-117.
7. Nikolsky E, Mehran R, Mintz GS, et al. Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions. J Endovasc Ther. 2004;11:60-70.
8. Heidrich H, Bullinger M, Cachovan M, et al. Quality of life in peripheral arterial occlusive disease. Multicenter study of quality of life characteristics with a newly developed disease-specific questionnaire [in German]. Med Klin. 1995;90:693-697.
9. Pell JP. Impact of intermittent claudication on quality of life. The Scottish Vascular Audit Group. Eur J Vasc Endovasc Surg. 1995;9:469-472.
10. Khaira HS, Hanger R, Shearman CP. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg. 1996;11:65-69.
11. McDermott MM, Fried L, Simonsick E, et al. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study. Circulation. 2000;101:1007-1012.
12. McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286:1599-1606.
13. Newman AB, Naydeck BL, Sutton-Tyrrell K, et al. The role of comorbidity in the assessment of intermittent claudication in older adults. J Clin Epidemiol. 2001;54:294-300.
14. Arfvidsson B, Karlsson J, Dahllof AG. The impact of intermittent claudication on quality of life evaluated by the Sickness Impact Profile technique. Eur J Clin Invest. 1993;23:741-745.
15. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg. 1996;23:104-115.
16. Cachovan M. Methods and results of controlled walking training in patients with peripheral arterial occlusive disease [in German], Z Arztl Fortbild Qualitätssich. 1999;93:626-632.
17. Chong PF, Golledge J, Greenhalgh RM, et al. Exercise therapy or angioplasty? A summation analysis. Eur J Vasc Endovasc Surg. 2000;20:4-12.
18. Diehm C, Balzer K, Bisler H, et al. Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trial. J Vasc Surg. 1997;25:537-544.
19. Dawson DL, Cutler BS, Meissner MH, et al. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective double-blind trial. Circulation. 1998;98:678-686.
20. Kieffer E, Bahnini A, Mouren X, et al. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical ischemia Study (NCIS). Int Angiol. 2001;20:58-65.
21. Lundgren F, Dahllof A, Lundholm K, et al. Intermittent claudication: surgical reconstruction or physical training? A prospective randomized trial of treatment efficiency. Ann Surg. 1989;209:346-355.
22. Wilson SE, Wolf GL, Cross AP. Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis: report of a prospective randomized trial in a selected group of patients. J Vasc Surg. 1989;9:1-9.
23. Holm J, Arfvidsson B, Jivegard L, et al. Chronic lower limb ischemia: a prospective randomized controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg. 1991;5:517-522.
24. Regensteiner JG, Hargarten ME, Rutherford RB, et al. Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication. Angiology. 1993;44:1-10.
25. Reifler DR, Feinglass J, Slavensky R, et al. Functional outcomes for patients with intermittent claudication: bypass surgery versus angioplasty versus noninvasive management. J Vasc Med Biol. 1994;5:203-211.
26. Cook TA, O'Regan M, Galland RB. Quality of life following percutaneous transluminal angioplasty for claudication. Eur J Vasc Endovasc Surg. 1996;11:191-194.
27. Whyman MR, Fowkes FG, Kerracher EM, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. J Vasc Surg. 1997;26:551-557.
28. Feinglass J, McCarthy WJ, Slavensky R, et al. Functional status and walking ability after lower extremity bypass grafting or angioplasty for intermittent claudication: results from a prospective outcomes study. J Vasc Surg. 2000;31:93-103.
29. Feinglass J, McCarthy WJ, Slavensky R. Effect of lower extremity blood pressure on physical functioning in patients with intermittent claudication. The Chicago Claudication Outcomes Research Group. J Vasc Surg. 1996;24:503-512.
30. Parmelee PA, Thuras PD, Katz IR, et al. Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc. 1995;43:130-137.
31. Conwell Y, Forbes NT, Cox C, et al. Validation of a measure of physical illness burden at autopsy: the Cumulative Illness Rating Scale. J Am Geriatr Soc. 1993;41:38-41.
32. Bullinger M, Cachovan M, Creutzig A, et al. Development of an illness-specific instrument for assessment of quality of life in patients with arterial occlusive disease (Peripheral Arterial Occlusive Disease 86 Questionnaire) [in German]. Vasa. 1996;25:32-40.